Jennifer Ji Young Lee

Jennifer Ji Young Lee

Auto-generated profile, based on publicly available information

Jennifer Ji Young Lee

J.J.Y. Lee, SickKids Hospital, Toronto, Ontario, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
SKStephanie C Kulhawy-Wibe
Stephanie C Kulhawy-Wibe
JWJessica Widdifield
Jessica Widdifield
JLJennifer J Y Lee
Jennifer J Y Lee
JTJ Carter Thorne
J Carter Thorne
EYElaine Yacyshyn
Elaine Yacyshyn
CBClaire E H Barber
Claire E H Barber
Objective.: The Canadian Rheumatology Association (CRA) launched the Workforce and Wellness Survey to update the Canadian rheumatology workforce characteristics.Methods.: The survey included demographic and practice information, pandemic effects, and the Mini Z survey to assess burnout. French and English survey versions were distributed to CRA members electronically between October 14, 2020, and March 5, 2021. The number of full-time equivalent (FTE) rheumatologists per 75,000 population was estimated from the median proportion of time in clinical practice multiplied by provincial rheumatologist numbers from the Canadian Medical Association.Results.: Forty-four percent (183/417) of the estimated practicing rheumatologists (149 adult; 34 pediatric) completed the survey. The median age was 47 years, 62% were female, and 28% planned to retire within the next 5–10 years. Respondents spent a median of 65% of their time in clinical practice. FTE rheumatologists per 75,000 population were 0.62 nationally and ranged between 0.00 and 0.70 in each province/territory. This represents a deficit of 1–78 FTE rheumatologists per province/territory and 194 FTE rheumatologists nationally to meet the CRA’s workforce benchmark. Approximately half of survey respondents reported burnout (51%). Women were more likely to report burnout (OR 2.86, 95% CI 1.42–5.93). Older age was protective against burnout (OR 0.95, 95% CI 0.92–0.99). As a result of the pandemic, 97% of rheumatologists reported spending more time engaged in virtual care.Conclusion.: There is a shortage of rheumatologists in Canada. This shortage may be compounded by the threat of burnout to workforce retention and productivity. Strategies to address these workforce issues are needed urgently.

4 February 2022 in Pediatrics
Verified
Journal Article
Closed access
PDF file
JLJennifer J. Y. Lee
Jennifer J. Y. Lee
ELEthan Lin
Ethan Lin
JWJessica Widdifield
Jessica Widdifield
QMQuenby Mahood
Quenby Mahood
BMBrian W. McCrindle
Brian W. McCrindle
BFBrian Michael Feldman
Brian Michael Feldman
Video Abstract Video Abstract It is uncertain if children with Kawasaki Disease (KD) are at risk for non-cardiac diseases and if children with KD but without coronary artery aneurysms (CAA) are at risk for long-term cardiac complications. To determine the long-term mortality and prognosis of children after KD. Medline, Embase, and the Cochrane Central Register. Controlled trials and observational studies were included if they included children with KD and reported mortality, major adverse cardiovascular events (MACE), chronic cardiac or other disease over an average follow-up of ≥1 year. Data extracted included sample size, age at diagnosis, the proportion with coronary artery aneurysms (CAA), follow-up duration, and outcome(s). Seventy-four studies were included. Thirty-six studies reported mortality, 55 reported a cardiac outcome, and 12 reported a noncardiac outcome. Survival ranged from 92% to 99% at 10 years, 85% to 99% at 20 years, and 88% to 94% at 30 years. MACE-free survival, mostly studied in those with CAA, varied from 66% to 91% at 10 years, 29% to 74% at 20 years, and 36% to 96% at 30 years. Seven of 10 studies reported an increased risk in early atherosclerosis. All 6 included studies demonstrated an increased risk in allergic diseases. Our study may have missed associated chronic comorbidities because short-term studies were excluded. The majority of outcomes were evaluated in East-Asian patients, which may limit generalizability. Studies frequently excluded patients without CAA and did not compare outcomes to a comparison group. Studies demonstrate >90% survival up to 30 years follow-up. MACE is observed in children with CAA, but is not well studied in those without CAA.

28 June 2022 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
JLJennifer J. Y. Lee
Jennifer J. Y. Lee
SESimon W. M. Eng
Simon W. M. Eng
JGJaime Guzman
Jaime Guzman
CDCiáran M. Duffy
Ciáran M. Duffy
LTLori B. Tucker
Lori B. Tucker
TIthe ReACCh‐Out Investigators
the ReACCh‐Out Investigators

1 September 2021 in Best Practice & Research Clinical Rheumatology
Verified
Journal Article
Closed access
JLJennifer J.Y. Lee
Jennifer J.Y. Lee
MGMonique A.M. Gignac
Monique A.M. Gignac
SJSindhu R. Johnson
Sindhu R. Johnson

26 June 2019 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
JLJennifer J. Y. Lee
Jennifer J. Y. Lee
AAAlhanouf Alsaleem
Alhanouf Alsaleem
GCGrace P. K. Chiang
Grace P. K. Chiang
ELElizaveta Limenis
Elizaveta Limenis
WSWatchareewan Sontichai
Watchareewan Sontichai
RLRonald M. Laxer
Ronald M. Laxer
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) refers to a complex group of systemic vasculitides that are characterized by primary small-to-medium sized blood vessel inflammation with the presence of autoantibodies known as ANCA. AAV diseases include Granulomatosis with Polyangiitis (GPA), Eosinophilic Granulomatosis with Polyangiitis (EGPA), and Microscopic Polyangiitis (MPA). AAVs are challenging conditions associated with high cumulative disease and treatment related morbidity and mortality. Given its rarity and the resulting paucity of pediatric-specific clinical trial evidence, pediatric rheumatologists have had to often extrapolate from adult literature for management and therapeutic decisions. The aim of this review is to provide a comprehensive overview of the important findings and overall conclusions of critical landmark clinical trials in the induction and maintenance treatments in adult AAV for the pediatric rheumatologist. This review also highlights the outcomes of recent pediatric AAV observational studies and discusses the future research priorities in pediatric AAV management.

1 August 2021 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
JLJennifer J.Y. Lee
Jennifer J.Y. Lee
RLRonald M. Laxer
Ronald M. Laxer
BFBrian Michael Feldman
Brian Michael Feldman
CBClaire E.H. Barber
Claire E.H. Barber
MBMichelle Batthish
Michelle Batthish
OAon behalf of the Pediatrics Committee of the Canadian Rheumatology Association
on behalf of the Pediatrics Committee of the Canadian Rheumatology Association
Objective: To examine the Canadian pediatric rheumatology workforce and care processes.Methods: Pediatric rheumatologists and allied health professionals (AHPs) participated. A designee from each academic center provided workforce information including the number of providers, total and breakdown of full-time equivalents (FTEs), and triage processes. We calculated the clinical FTE (cFTE) available per 75,000 (recommended benchmark) and 300,000 (adjusted) children using 2019 census data. The national workforce deficit was calculated as the difference between current and expected cFTEs. Remaining respondents were asked about ambulatory practices.Results: The response rate of survey A (workforce information) and survey B (ambulatory practice information) was 100% and 54%, respectively. The majority of rheumatologists (91%) practiced in academic centers. The median number of rheumatologists per center was 3 (IQR 3) and median cFTE was 1.9 (IQR 1.5). The median cFTE per 75,000 was 0.2 (IQR 0.3), with a national deficit of 80 cFTEs. With the adjusted benchmark, there was no national deficit, but there was a regional maldistribution of rheumatologists. All centers engaged in multidisciplinary practices with a median of 4 different AHPs, although the median FTE for AHPs was ≤ 1. Most centers (87%) utilized a centralized triage process. Of 9 (60%) centers that used an electronic triage process, 6 were able to calculate wait times. Most clinicians integrated quality improvement practices, such as previsit planning (67%), postvisit planning (68%), and periodic health outcome monitoring (36–59%).Conclusion: This study confirms a national deficit at the current recommended benchmark. Most rheumatologists work in multidisciplinary teams, but AHP support may be inadequate.